Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 471

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Early safety indicators of COVID-19 convalescent plasma in 5000 patients

Open access
Joyner, Michael J., Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon W., Bruno, Katelyn A., Klassen, Stephen A., Carter, Rickey E., Klompas, Allan M., Wiggins, Chad C., Shepherd, John R.A., Rea, Robert F., Whelan, Emily R., Clayburn, Andrew J., Spiegel, Matthew R., Johnson, Patrick W., Lesser, Elizabeth R., Baker, Sarah E., Larson, Kathryn F., Ripoll, Juan G., Andersen, Kylie J., Hodge, David O., Kunze, Katie L., Buras, Matthew R., Vogt, Matthew N.P., Herasevich, Vitaly, Dennis, Joshua J., Regimbal, Riley J., Bauer, Philippe R., Blair, Janis E., Van Buskirk, Camille M., Winters, Jeffrey L., Stubbs, James R., Paneth, Nigel S., Verdun, Nicole C., Marks, Peter, Casadevall, Arturo·2020·Journal of Clinical Investigation

Abstract

BACKGROUND: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. METHODS: Thus, we analyzed key safety metrics after transfusion of ABO-compatible human COVID-19 convalescent plasma in 5,000 hospitalized adults with severe or life threatening COVID-19, with 66% in the intensive care unit, as part of the US FDA Expanded Access Program for COVID-19 convalescent plasma. RESULTS: The incidence of all serious adverse events (SAEs) in the first four hours after transfusion was <1%, including mortality rate (0.3%). Of the 36 reported SAEs, there were 25 reported incidences of related SAEs, including mortality (n=4), transfusion-associated circulatory overload (TACO; n=7), transfusion-related acute lung injury (TRALI; n=11), and severe allergic transfusion reactions (n=3). However, only 2 (of 36) SAEs were judged as definitely related to the convalescent plasma transfusion by the treating physician. The seven-day mortality rate was 14.9%. CONCLUSION: Given the deadly nature of COVID-19 and the large population of critically-ill patients included in these analyses, the mortality rate does not appear excessive. These early indicators suggest that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci140200

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 471

Metadata

Authors
Joyner, M. J., Wright, R. S., Fairweather, D., Senefeld, J. W., Bruno, K. A., Klassen, S. A., Carter, R. E., Klompas, A. M., Wiggins, C. C., Shepherd, J. R. A., Rea, R. F., Whelan, E. R., Clayburn, A. J., Spiegel, M. R., Johnson, P. W., Lesser, E. R., Baker, S. E., Larson, K. F., Ripoll, J. G., Andersen, K. J., Hodge, D. O., Kunze, K. L., Buras, M. R., Vogt, M. N. P., Herasevich, V., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Paneth, N. S., Verdun, N. C., Marks, P., & Casadevall, A.
Venue
Journal of Clinical Investigation
Published
2020-08-10
Volume
130
Issue
9
Pages
4791-4797
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3034286795
Cited by
471
References
27
FWCI
13.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early safety indicators of COVID-19 convalescent plasma in 5000 patients. https://app.cochat.ai/papers/10.1172/jci140200
The paper
Joyner, M. J., Wright, R. S., Fairweather, D., Senefeld, J. W., Bruno, K. A., Klassen, S. A., Carter, R. E., Klompas, A. M., Wiggins, C. C., Shepherd, J. R. A., Rea, R. F., Whelan, E. R., Clayburn, A. J., Spiegel, M. R., Johnson, P. W., Lesser, E. R., Baker, S. E., Larson, K. F., Ripoll, J. G., . . . Casadevall, A. (2020). Early safety indicators of COVID-19 convalescent plasma in 5000 patients. Journal of Clinical Investigation. https://doi.org/10.1172/jci140200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.